Newsletter
| HPV Screening |
|
PapilloCheck®- HPV Screening (Greiner Bio-One®)
DescriptionThe infection by papillomarivus at risk (HPV HR) is a condition required for pre-cancer and cervical cancer development.
SpecificationsThe test is based on the detection of E1 gene fragment of 24 HPV types. The amplification products are hybridized for only 15 minutes at room temperature. Every chip has 12 arrays allowing simultaneous analysis of 12 samples. During hybridization, probes are labelled with fluorescent dyes. Chips are washed to eliminate unbound DNA and then analysed. PapilloCheck® features:
PapilloCheck® kit content
|
![]() |
• 5 slides with 12 tests each • Mastermix PCR • Hybridization buffer • Wash Buffer A • Wash Buffer B • CheckReport™ software with user guide |
| • Certified in-vitro diagnostic (IVD) for simultaneous genotyping of 24 different types of HPV. • Controls integrated on the chip – Controls and patient in a single sample. • High specificity and high sensibility. • Automated scan, evaluation and HPV report generation. |
Protocol
Protocol: less than 4 h (including PCR )
![]() 1. Sample collection: Cervical cells, biopsy 30 min |
![]() 2. DNA Extraction: 30 min |
![]() 3. PCR: 120 min |
![]() 4. Hybridization:
15 min at the ambient |
![]() 5. Washes: 2 min |
![]() 6. Scaning: 10 min |
7. Evaluation:5 min For further information, please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it |
Ask a Quote








